|
|
Line 94: |
Line 94: |
| overflow: hidden; | | overflow: hidden; |
| margin: 0 auto; | | margin: 0 auto; |
- | color:white; | + | color: white; |
| } | | } |
| * html body { | | * html body { |
Line 112: |
Line 112: |
| height: auto; | | height: auto; |
| float: left; | | float: left; |
- | padding-bottom: 50px;
| + | padding-bottom: 50px; |
| z-index: 10; | | z-index: 10; |
- | color:white; | + | color: white; |
| } | | } |
| .content2 { | | .content2 { |
Line 132: |
Line 132: |
| text-align: justify; | | text-align: justify; |
| overflow: auto; | | overflow: auto; |
- | background-color:black; | + | background-color: black; |
- | opacity:0.85; | + | opacity: 0.85; |
| } | | } |
| .content2 .text p span { | | .content2 .text p span { |
Line 166: |
Line 166: |
| text-align: center; | | text-align: center; |
| } | | } |
- | h1,h2,h3,h4,h5 {color:white;} | + | h1, h2, h3, h4, h5 { |
| + | color: white; |
| + | } |
| .smallbox .img { | | .smallbox .img { |
| height: 105px; | | height: 105px; |
Line 263: |
Line 265: |
| <div class="text"> | | <div class="text"> |
| <h2>Team</h2> | | <h2>Team</h2> |
- | <div id="slider" style="opacity:1;"> | + | <div id="slider" style="opacity: 1;"> |
| <img alt="" src="https://static.igem.org/mediawiki/2010/e/e7/Metu-slide1.jpg"> | | <img alt="" src="https://static.igem.org/mediawiki/2010/e/e7/Metu-slide1.jpg"> |
| <img alt="" src="https://static.igem.org/mediawiki/2010/e/e1/Metu-slide2.jpg"> | | <img alt="" src="https://static.igem.org/mediawiki/2010/e/e1/Metu-slide2.jpg"> |
Line 562: |
Line 564: |
| <li>Lethbridge</li> | | <li>Lethbridge</li> |
| <li>WashU</li> | | <li>WashU</li> |
- | <li>...</li>
| |
- | <li>...</li>
| |
- | <li>...</li>
| |
| </ul> | | </ul> |
| <li>Out of 244 participants between 10 to 22.10.2010, 57% of the | | <li>Out of 244 participants between 10 to 22.10.2010, 57% of the |
Line 814: |
Line 813: |
| all parts registry users as a build-in option in the next version of | | all parts registry users as a build-in option in the next version of |
| BioGuide in iGEM 2011. </i></p> | | BioGuide in iGEM 2011. </i></p> |
- | <h4>NEW PARTS REGISTRY FORM SUGGESTED FOR THE NEW STANDARDS</h4> | + | <br> |
- | <p><a href="">Link out to the form</a></p> | + | <h2>NEW PARTS REGISTRY FORM SUGGESTED FOR THE NEW STANDARDS</h2> |
| + | <img src="https://static.igem.org/mediawiki/2010/1/17/Metu-form1.png"> |
| + | <h3>Description</h3> |
| + | <p>Warning Boxes: </p> |
| + | <ul> |
| + | <li>If Out-dated, un-available and not-characterized parts exist |
| + | in the Registry of Standard Parts, bring to an archive after the |
| + | consent of the designer. Divide archive into three title: Out-dated, |
| + | un-available and not-characterized parts </li> |
| + | <li>Besides shown as “works”, in the works box there should be explanation |
| + | whether the part is characterized or non-characterized. </li> |
| + | <li>Parts should be updated regularly by the designers </li> |
| + | <li>Excluding the low ranking parts or the parts with negative feedback |
| + | from the future plates </li> |
| + | </ul> |
| + | <p>Characterization Boxes: </p> |
| + | <ul> |
| + | <li>transcriptional efficiency </li> |
| + | <li>mRNA lifetime </li> |
| + | <li>ribosome binding efficiency </li> |
| + | <li>translation initiation and efficiency </li> |
| + | <li>protein lifetime </li> |
| + | <li>protein concentration </li> |
| + | <li>protein multimerization </li> |
| + | <li>protein-DNA binding rates and efficiencies </li> |
| + | <li>cooperative effects with other molecules </li> |
| + | <li>RNA polymerase effects </li> |
| + | <li>system copy count </li> |
| + | </ul> |
| + | <img src="https://static.igem.org/mediawiki/2010/9/91/Metu-form2.png"> |
| + | <h3>Desription</h3> |
| + | <p>Search box </p> |
| + | <ul> |
| + | <li>with click options </li> |
| + | <li>options: searched parts are: |
| + | <ul> |
| + | <li>Available </li> |
| + | <li>Length OK </li> |
| + | <li>Building </li> |
| + | <li>Planning </li> |
| + | <li>Missing </li> |
| + | <li>Unavailable </li> |
| + | </ul> |
| + | </li> |
| + | </ul> |
| + | <p>according to the clicks of above options, search is modified</p> |
| + | <img src="https://static.igem.org/mediawiki/2010/5/54/Metu-form3.png"> |
| + | <img src="https://static.igem.org/mediawiki/2010/1/1d/Metu-form4.png"> |
| + | <p>Assume on the part image; </p> |
| + | <ul> |
| + | <li>part DNA sequence is not confirmed, then tag with "non-confirmed |
| + | DNA sequence" </li> |
| + | <li>non-characterized parts in the Parts Registry are not characterized |
| + | further, then it will be tagged as "deprecated" </li> |
| + | </ul> |
| + | <p>also: </p> |
| + | <ul> |
| + | <li>comment box stated that any team can make comment about experiences |
| + | with the part is opened </li> |
| + | <li>boxes which had been not filled with the data are highlighted; |
| + | <ul> |
| + | <li>transcriptional efficiency </li> |
| + | <li>mRNA lifetime </li> |
| + | <li>ribosome binding efficiency </li> |
| + | <li>translation initiation and efficiency </li> |
| + | <li>protein lifetime </li> |
| + | <li>protein concentration </li> |
| + | <li>protein multimerization </li> |
| + | <li>protein-DNA binding rates and efficiencies </li> |
| + | <li>cooperative effects with other molecules </li> |
| + | <li>RNA polymerase effects </li> |
| + | <li>system copy count </li> |
| + | </ul> |
| + | </li> |
| + | <li>if the part is not characterized but "works" then a "Qualitative |
| + | part" tag is added </li> |
| + | <li>besides "works", "Characterized" or "non-characterized" box |
| + | is added </li> |
| + | <li>ranking/rating stars for the parts voted by the other iGEM users |
| + | which indicate how well the parts perform in different laboratories |
| + | is added. For example 4.5 star voted by 27 teams (number of stars |
| + | and number of votes) </li> |
| + | </ul> |
| </div> | | </div> |
| </div> | | </div> |
Line 881: |
Line 962: |
| </div> | | </div> |
| <div id="miscellaneous3" class="item"> | | <div id="miscellaneous3" class="item"> |
- | <div class="conty of Standard Parts </h4> | + | <div class="conty of Standard Parts </h4> |
- | <ul> | + | <ul> |
- | <li><strong>56% of participants think that it is not easy to search | + | <li><strong>56% of participants think that it is not easy to search |
- | for the parts in Registry of Standard Parts.</strong> Many comments | + | for the parts in Registry of Standard Parts.</strong> Many comments |
| indicate a need for a better search engine and more flexible keyword | | indicate a need for a better search engine and more flexible keyword |
| search options, especially excepting aliases. Also many are longing | | search options, especially excepting aliases. Also many are longing |
| for recognizable parts names, which will ease searching with keyword. | | for recognizable parts names, which will ease searching with keyword. |
- | </li> | + | </li> |
- | </ul> | + | </ul> |
- | <p><i>Partnership with Google and enforcing standardized parts names | + | <p><i>Partnership with Google and enforcing standardized parts names |
- | are suggested </i></p> | + | are suggested </i></p> |
- | <p><i>As a global organization iGEM can offer the Parts Registry in | + | <p><i>As a global organization iGEM can offer the Parts Registry in |
| different languages and more illustrations describing how the system | | different languages and more illustrations describing how the system |
- | works.</i></p> | + | works.</i></p> |
- | <h4>Content of Registry of Standard Parts </h4> | + | <h4>Content of Registry of Standard Parts </h4> |
- | <ul> | + | <ul> |
- | <li><strong>57% of participants agree that the number of parts registered | + | <li><strong>57% of participants agree that the number of parts registered |
- | in the Registry of Standard Parts is not enough for their projects.</strong> | + | in the Registry of Standard Parts is not enough for their projects.</strong> |
- | </li> | + | </li> |
- | <li><strong>55% of participants think that there are enough and | + | <li><strong>55% of participants think that there are enough and |
| useful parts distributed in iGEM Plates that we can use in our projects. | | useful parts distributed in iGEM Plates that we can use in our projects. |
- | </strong></li> | + | </strong></li> |
- | </ul> | + | </ul> |
- | <p>Even though most agree the number of parts in the registry is impressive, | + | <p>Even though most agree the number of parts in the registry is impressive, |
| still they find it limited when it comes to design different devices | | still they find it limited when it comes to design different devices |
| for diverse applications especially in different species other than | | for diverse applications especially in different species other than |
Line 910: |
Line 991: |
| parts, especially protein coding sequences and promoter-RBS , they can | | parts, especially protein coding sequences and promoter-RBS , they can |
| design devices according to the needs of the community instead of designing | | design devices according to the needs of the community instead of designing |
- | what can simply be assembled into a device. </p> | + | what can simply be assembled into a device. </p> |
- | <p><i>Encouraging development of vectors and standards for new species | + | <p><i>Encouraging development of vectors and standards for new species |
| and new standardized parts in different research areas is suggested. | | and new standardized parts in different research areas is suggested. |
- | </i></p> | + | </i></p> |
- | <p><i>Enforcing submission of right DNA sequences and working conditions | + | <p><i>Enforcing submission of right DNA sequences and working conditions |
- | for each part is suggested.</i> </p> | + | for each part is suggested.</i> </p> |
- | <p><i>Few recommend expanding iGEM into a collaborative effort rather | + | <p><i>Few recommend expanding iGEM into a collaborative effort rather |
| than an undergraduate tournament, which will increase the number and | | than an undergraduate tournament, which will increase the number and |
| the diversity of the parts designed and submitted all throughout the | | the diversity of the parts designed and submitted all throughout the |
- | year. </i></p> | + | year. </i></p> |
- | <h4>Submission to the Parts Registry </h4> | + | <h4>Submission to the Parts Registry </h4> |
- | <ul> | + | <ul> |
- | <li><strong>52% of participants said that they have not encountered | + | <li><strong>52% of participants said that they have not encountered |
- | difficulties during submitting parts.</strong> Even though participants | + | difficulties during submitting parts.</strong> Even though participants |
| are satisfied with the web interface of the registry, most complains | | are satisfied with the web interface of the registry, most complains |
- | about the pSB1C3 as the new standard plasmid to submit DNA. </li> | + | about the pSB1C3 as the new standard plasmid to submit DNA. </li> |
- | <li><strong>71% of participants are like minded with our team's | + | <li><strong>71% of participants are like minded with our team's |
| opinion, which is that The nomenclature of part IDs such as construct, | | opinion, which is that The nomenclature of part IDs such as construct, |
| device, composite parts, protein generator, is confusing as there | | device, composite parts, protein generator, is confusing as there |
- | is no consensus on how to use them correctly.</strong> </li> | + | is no consensus on how to use them correctly.</strong> </li> |
- | </ul> | + | </ul> |
- | <p><i>Terminology and categorization used on iGEM’s Parts Registry should | + | <p><i>Terminology and categorization used on iGEM’s Parts Registry should |
| be re-described and correct use of terminology should be enforced during | | be re-described and correct use of terminology should be enforced during |
- | the submission process.</i> </p> | + | the submission process.</i> </p> |
- | <ul> | + | <ul> |
- | <li><strong>75% of participants agree that different, specified | + | <li><strong>75% of participants agree that different, specified |
| submission interfaces should be designed for contructs, promoter, | | submission interfaces should be designed for contructs, promoter, |
- | RBS, CDS and terminals is needed during Registry of Standard Parts.</strong> | + | RBS, CDS and terminals is needed during Registry of Standard Parts.</strong> |
| But, there are very strong and valid arguments against it such as, | | But, there are very strong and valid arguments against it such as, |
| losing the flexibility of the registry will not allow future submission | | losing the flexibility of the registry will not allow future submission |
- | of unclassified parts. </li> | + | of unclassified parts. </li> |
- | </ul> | + | </ul> |
- | <p><i>We suggest keeping the parts submission interface as is, until | + | <p><i>We suggest keeping the parts submission interface as is, until |
- | these concerns are addressed.</i> </p> | + | these concerns are addressed.</i> </p> |
- | <ul> | + | <ul> |
- | <li><strong>75% of participants agree that Out-dated, un-available | + | <li><strong>75% of participants agree that Out-dated, un-available |
| and not-characterized parts in the Registry of Standard Parts should | | and not-characterized parts in the Registry of Standard Parts should |
- | be removed to an archive after the consent of the designer.</strong> | + | be removed to an archive after the consent of the designer.</strong> |
- | </li> | + | </li> |
- | </ul> | + | </ul> |
- | <p>“It would be great to see some sort of organization like this! I | + | <p>“It would be great to see some sort of organization like this! I |
| agree that unavailable parts should be followed up on and removed if | | agree that unavailable parts should be followed up on and removed if |
| necessary. I also think that parts which are not sufficiently documented | | necessary. I also think that parts which are not sufficiently documented |
| should be highlighted in some way. Once these parts are identified, | | should be highlighted in some way. Once these parts are identified, |
| teams can actively characterize them as part of their projects or as | | teams can actively characterize them as part of their projects or as |
- | side projects.” </p> | + | side projects.” </p> |
- | <p>“Think about these things: (i) who decides when a part is out-dated, | + | <p>“Think about these things: (i) who decides when a part is out-dated, |
| and how can that person know that an old part cannot have a novel use | | and how can that person know that an old part cannot have a novel use |
| in the future? (ii) likewise, an uncharacterized part may be both characterized | | in the future? (ii) likewise, an uncharacterized part may be both characterized |
- | and used in the future” </p> | + | and used in the future” </p> |
- | <p><i>We suggest building a backup system, such as an archive, to sort | + | <p><i>We suggest building a backup system, such as an archive, to sort |
| out the rarely used, un-available and un-categorized parts until they | | out the rarely used, un-available and un-categorized parts until they |
- | are in line with the enforced standards.</i> </p> | + | are in line with the enforced standards.</i> </p> |
- | <ul> | + | <ul> |
- | <li><strong>91% of participants have same opinion with us, which | + | <li><strong>91% of participants have same opinion with us, which |
| is that standardization of the nomenclatures used for each different | | is that standardization of the nomenclatures used for each different |
- | composition of parts is necessary.</strong></li> | + | composition of parts is necessary.</strong></li> |
- | </ul> | + | </ul> |
- | <h4>Standards that should be enforced and Additional New Standards | + | <h4>Standards that should be enforced and Additional New Standards |
- | </h4> | + | </h4> |
- | <p>According to our survey, from high rated to low, these standards | + | <p>According to our survey, from high rated to low, these standards |
| have been rated which has been used while assigning a name to parts | | have been rated which has been used while assigning a name to parts |
- | </p> | + | </p> |
- | <ul> | + | <ul> |
- | <li><strong>33% Type of part</strong> </li> | + | <li><strong>33% Type of part</strong> </li> |
- | <li><strong>17% Input</strong> </li> | + | <li><strong>17% Input</strong> </li> |
- | <li><strong>17% Output</strong> </li> | + | <li><strong>17% Output</strong> </li> |
- | <li><strong>14% Version</strong> </li> | + | <li><strong>14% Version</strong> </li> |
- | <li><strong>10% Year</strong> </li> | + | <li><strong>10% Year</strong> </li> |
- | <li><strong>9% Group</strong> </li> | + | <li><strong>9% Group</strong> </li> |
- | </ul> | + | </ul> |
- | <p>Along with above, having short recognizable part names along with | + | <p>Along with above, having short recognizable part names along with |
| function and performance , Genbank/EMBL link and organism information | | function and performance , Genbank/EMBL link and organism information |
- | is important. </p> | + | is important. </p> |
- | <ul> | + | <ul> |
- | <li><strong>93% of participants have said that for the parts that | + | <li><strong>93% of participants have said that for the parts that |
| are marked as “WORKS” distinguishing the parts with quantitative | | are marked as “WORKS” distinguishing the parts with quantitative |
- | experimental validation vs parts without this information is important.</strong> | + | experimental validation vs parts without this information is important.</strong> |
| Most participants have encountered with similar problems about parts | | Most participants have encountered with similar problems about parts |
| that don’t work under their lab conditions or works but not they | | that don’t work under their lab conditions or works but not they |
- | were claimed for. </li> | + | were claimed for. </li> |
- | <li><strong>89% of participants have same opinion with us, which | + | <li><strong>89% of participants have same opinion with us, which |
| is that iGEM should sub-categorize the “WORKS” comment into 1) “Quantitative” | | is that iGEM should sub-categorize the “WORKS” comment into 1) “Quantitative” |
| for parts which are characterized with experiments and 2) “Qualitative” | | for parts which are characterized with experiments and 2) “Qualitative” |
| for parts which are not characterized will be an appropriate measure | | for parts which are not characterized will be an appropriate measure |
- | for standardization of Biobrick database.</strong> </li> | + | for standardization of Biobrick database.</strong> </li> |
- | </ul> | + | </ul> |
- | <p><i>In order to overcome these problems we suggest enforcing the working | + | <p><i>In order to overcome these problems we suggest enforcing the working |
| conditions title for the registry entrance, in order to collect quantitative | | conditions title for the registry entrance, in order to collect quantitative |
| experimental details on submitted parts, which might slow down the registration | | experimental details on submitted parts, which might slow down the registration |
- | process but will definitely increase the quality of the database.</i> | + | process but will definitely increase the quality of the database.</i> |
- | </p> | + | </p> |
- | <ul> | + | <ul> |
- | <li><strong>61% of participants agree that POPS (Polymerase Per | + | <li><strong>61% of participants agree that POPS (Polymerase Per |
| Second) should be assigned to every part or biobricks with a promoter, | | Second) should be assigned to every part or biobricks with a promoter, |
| where appropriate. - 57% of participants have been agree that RIPS | | where appropriate. - 57% of participants have been agree that RIPS |
| (Ribosome per Second) should be assigned to every part or biobricks | | (Ribosome per Second) should be assigned to every part or biobricks |
- | with a RBS brick.</strong> </li> | + | with a RBS brick.</strong> </li> |
- | </ul> | + | </ul> |
- | <p>Though most participants agree the need for POPS and RBS information | + | <p>Though most participants agree the need for POPS and RBS information |
| , they are concerned about the workload it would bring to individual | | , they are concerned about the workload it would bring to individual |
- | labs. </p> | + | labs. </p> |
- | <p>“To do this, the Registry need to define a reliable and easy method | + | <p>“To do this, the Registry need to define a reliable and easy method |
| of determining the PoPS for teams to use. However, I would say that | | of determining the PoPS for teams to use. However, I would say that |
| there are better systems for quantifying promoter output than PoPS, | | there are better systems for quantifying promoter output than PoPS, |
- | and they should be used instead, if possible”. </p> | + | and they should be used instead, if possible”. </p> |
- | <ul> | + | <ul> |
- | <li><strong>67% of participants have thought that entering POPS | + | <li><strong>67% of participants have thought that entering POPS |
| information should not be mandatory while submitting new parts. | | information should not be mandatory while submitting new parts. |
| Similarly, 65% of participants disagree that entering RIBS information | | Similarly, 65% of participants disagree that entering RIBS information |
- | should be mandatory while submitting new parts </strong></li> | + | should be mandatory while submitting new parts </strong></li> |
- | </ul> | + | </ul> |
- | <p>Even though the researchers feeling the need for this information | + | <p>Even though the researchers feeling the need for this information |
| they are shying away from requesting it as a mandatory title for parts | | they are shying away from requesting it as a mandatory title for parts |
| registry as it would be difficult for underfunded and inexperienced | | registry as it would be difficult for underfunded and inexperienced |
- | groups to perform these measurements. </p> | + | groups to perform these measurements. </p> |
- | <p><i>We strongly suggest starting a forum on how to quantify the performance | + | <p><i>We strongly suggest starting a forum on how to quantify the performance |
| of promoters and genes to bring an easy to measure standard for the | | of promoters and genes to bring an easy to measure standard for the |
| efficiency of the parts. Additionally iGEM should the responsibility | | efficiency of the parts. Additionally iGEM should the responsibility |
Line 1,034: |
Line 1,115: |
| under similar conditions and with experienced researchers, which will | | under similar conditions and with experienced researchers, which will |
| allow user to compare and contrast the efficiencies of the parts more | | allow user to compare and contrast the efficiencies of the parts more |
- | accurately. </i></p> | + | accurately. </i></p> |
- | <ul> | + | <ul> |
- | <li><strong>82% of participants have thought that information on | + | <li><strong>82% of participants have thought that information on |
| working conditions of the parts should be mandatory while submitting | | working conditions of the parts should be mandatory while submitting |
- | new parts.</strong> Most find submiting the detailed experimental | + | new parts.</strong> Most find submiting the detailed experimental |
| information and working conditions is crucial and even easier than | | information and working conditions is crucial and even easier than |
- | submitting measurements of POPS or RBS. </li> | + | submitting measurements of POPS or RBS. </li> |
- | </ul> | + | </ul> |
- | <h4>Definitions you would like to see at the Registry of Standard Parts | + | <h4>Definitions you would like to see at the Registry of Standard Parts |
- | </h4> | + | </h4> |
- | <ul> | + | <ul> |
- | <li><strong>Transcriptional efficiency 13%</strong> </li> | + | <li><strong>Transcriptional efficiency 13%</strong> </li> |
- | <li><strong>Protein lifetime 10%</strong> </li> | + | <li><strong>Protein lifetime 10%</strong> </li> |
- | <li><strong>Ribosome binding efficiency 10%</strong> </li> | + | <li><strong>Ribosome binding efficiency 10%</strong> </li> |
- | <li><strong>mRNA lifetime 9%</strong> </li> | + | <li><strong>mRNA lifetime 9%</strong> </li> |
- | <li><strong>Translation initiation and efficiency 9%</strong> | + | <li><strong>Translation initiation and efficiency 9%</strong> |
- | </li> | + | </li> |
- | <li><strong>Protein concentration 9%</strong> </li> | + | <li><strong>Protein concentration 9%</strong> </li> |
- | <li><strong>Cooperative effects with other molecules 9%</strong> | + | <li><strong>Cooperative effects with other molecules 9%</strong> |
- | </li> | + | </li> |
- | <li><strong>Protein-DNA binding rates and efficiencies 8%</strong> | + | <li><strong>Protein-DNA binding rates and efficiencies 8%</strong> |
- | </li> | + | </li> |
- | <li><strong>RNA polymerase affects 8% </strong></li> | + | <li><strong>RNA polymerase affects 8% </strong></li> |
- | <li><strong>System copy count 8%</strong> </li> | + | <li><strong>System copy count 8%</strong> </li> |
- | <li><strong>Protein multimerization 6%</strong> </li> | + | <li><strong>Protein multimerization 6%</strong> </li> |
- | </ul> | + | </ul> |
- | <p>Additional titles includes: Catalytic rates and affinities for substrates, | + | <p>Additional titles includes: Catalytic rates and affinities for substrates, |
| leakiness of promoter in lack of stimulus, POPS at various inducer/repressor | | leakiness of promoter in lack of stimulus, POPS at various inducer/repressor |
- | concentrations. </p> | + | concentrations. </p> |
- | <h4>Efficiency of the Database Entries </h4> | + | <h4>Efficiency of the Database Entries </h4> |
- | <ul> | + | <ul> |
- | <li><strong>86% of participants would like to see a ranking/rating | + | <li><strong>86% of participants would like to see a ranking/rating |
| system for the parts by the other iGEM users which will be one indication | | system for the parts by the other iGEM users which will be one indication |
- | of if a part is working and how well in different laboratories.</strong> | + | of if a part is working and how well in different laboratories.</strong> |
| Few had concerns about how well the rating system will work for | | Few had concerns about how well the rating system will work for |
| rarely used parts while the widely used parts would even more popular | | rarely used parts while the widely used parts would even more popular |
| due the the rating system. Still many believes this would be one | | due the the rating system. Still many believes this would be one |
| futher towards a peer-reviewed quality control system for the parts. | | futher towards a peer-reviewed quality control system for the parts. |
- | </li> | + | </li> |
- | <li><strong>61% of participants agreed that parts should be updated | + | <li><strong>61% of participants agreed that parts should be updated |
| regularly by the designers, where most agreed at least when there | | regularly by the designers, where most agreed at least when there |
- | is new information on the parts.</strong> It has also been suggested | + | is new information on the parts.</strong> It has also been suggested |
| to give permission to all the users of that part for updating information. | | to give permission to all the users of that part for updating information. |
- | </li> | + | </li> |
- | <li><strong>73% of participants have been agree with us that excluding | + | <li><strong>73% of participants have been agree with us that excluding |
| the low ranking parts or the parts with negative feedback from the | | the low ranking parts or the parts with negative feedback from the |
- | future plates will increase efficiency of the system.</strong> The | + | future plates will increase efficiency of the system.</strong> The |
| major concern about excluding any part is losing the variety of | | major concern about excluding any part is losing the variety of |
| parts in the database. Few recommends excluding only the parts that | | parts in the database. Few recommends excluding only the parts that |
- | are not working. </li> | + | are not working. </li> |
- | </ul> | + | </ul> |
- | <p>“Efficiency shouldn't be top priority in a database. First and foremost, | + | <p>“Efficiency shouldn't be top priority in a database. First and foremost, |
| data is the top priority. Excluding those parts would make the system | | data is the top priority. Excluding those parts would make the system |
- | more efficient” </p> | + | more efficient” </p> |
- | <p>“Some parts may be rare or new and have low efficiency, but can be | + | <p>“Some parts may be rare or new and have low efficiency, but can be |
| very important! Getting rid of them would eliminate any chance of improvement | | very important! Getting rid of them would eliminate any chance of improvement |
| to these parts, which not only a qualifier for an iGEM gold medal, but | | to these parts, which not only a qualifier for an iGEM gold medal, but |
- | also one of the focuses of biobricks.” </p> | + | also one of the focuses of biobricks.” </p> |
- | <p><i>We suggest excluding the parts not-working, low rated or with | + | <p><i>We suggest excluding the parts not-working, low rated or with |
| negative feedbacks from the annual distribution plates but still archive | | negative feedbacks from the annual distribution plates but still archive |
| them and make their data available through the parts registry. So the | | them and make their data available through the parts registry. So the |
Line 1,099: |
Line 1,180: |
| exotic part can search through the achieves and re-vitalize the parts | | exotic part can search through the achieves and re-vitalize the parts |
| stored there. The challenge of re-vitalization of parts can be encouraged | | stored there. The challenge of re-vitalization of parts can be encouraged |
- | as an collaborative effort.</i> </p> | + | as an collaborative effort.</i> </p> |
- | <h4>New Options for the Parts Registry Database </h4> | + | <h4>New Options for the Parts Registry Database </h4> |
- | <ul> | + | <ul> |
- | <li><strong>96% of participants are like minded with us that it | + | <li><strong>96% of participants are like minded with us that it |
| will be useful to have a link out to the gene/protein information | | will be useful to have a link out to the gene/protein information |
| of the parts and - %97 of participants have been agree that they | | of the parts and - %97 of participants have been agree that they |
| would like to know if a part is also involved in known biological | | would like to know if a part is also involved in known biological |
- | pathways.</strong> </li> | + | pathways.</strong> </li> |
- | </ul> | + | </ul> |
- | <p><strong>For receiving pathway information more participants have | + | <p><strong>For receiving pathway information more participants have |
| voted for NCBI Cog (59%) than KEGG pathways (38%) when the responses | | voted for NCBI Cog (59%) than KEGG pathways (38%) when the responses |
| for both has been distributed among the choices according to response | | for both has been distributed among the choices according to response |
- | rates.</strong> Adding the blast option to the parts registry has also | + | rates.</strong> Adding the blast option to the parts registry has also |
| been suggested to locate parts of interest. We are sure all of us would | | been suggested to locate parts of interest. We are sure all of us would |
| like to see gene-protein and pathway information if these information | | like to see gene-protein and pathway information if these information |
| was integrated into the database and offered automatically for each | | was integrated into the database and offered automatically for each |
- | entry in the database.</p> | + | entry in the database.</p> |
- | <p><i>We are planning to provide this information about the parts to | + | <p><i>We are planning to provide this information about the parts to |
| all parts registry users as a build-in option in the next version of | | all parts registry users as a build-in option in the next version of |
- | BioGuide in iGEM 2011. </i></p> | + | BioGuide in iGEM 2011. </i></p> |
- | <h4>NEW PARTS REGISTRY FORM SUGGESTED FOR THE NEW STANDARDS</h4> | + | <h4>NEW PARTS REGISTRY FORM SUGGESTED FOR THE NEW STANDARDS</h4> |
- | <p><a href="">Link out to the form</a></p> | + | <p><a href="> |
- | </div>
| + | Link out to the form</a><p></p> |
| </div> | | </div> |
| + | </div> |
| </div> | | </div> |
| <div class="clear"> | | <div class="clear"> |